Please login to the form below

Not currently logged in
Email:
Password:

Webinars

  • Assessing early market opportunity

    Wednesday, 19 April 2017 - 3:00 pm

    To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • PC: Are you Patient Centric or just Politically Correct?

    Tuesday, 24 January 2017 - 3:00 pm

    Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Communicating innovation to payers and policy makers

    Monday, 28 November 2016 - 3:00 pm

    Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Immuno-oncology's evolution: implications for pharma market researche

    Thursday, 17 November 2016 - 3:00 pm

    Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Scale & Strategy: Essential tools for transforming the commercial model

    Wednesday, 9 November 2016 - 2:00 pm

    Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Driving adoption of Commercial Analytic solutions Driving adoption of Commercial Analytic solutions

    Tuesday, 25 October 2016 - 3:00 pm

    Measuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making

    Tuesday, 4 October 2016 - 3:00 pm

    Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Strengthening market access deliverables by harnessing the patient journey

    Wednesday, 14 September 2016 - 3:00 pm

    In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • The value of early asset development and commercialisation

    Wednesday, 13 July 2016 - 3:00 pm

    Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets to succeed.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Developing medical education that advances patient outcomes

    Thursday, 30 June 2016 - 2:00 pm

    As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice and advancing patient outcomes.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Customer engagement design in pharma

    Thursday, 19 May 2016 - 3:00 pm

    In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Rare diseases: Regulatory and reimbursement submissions, the challenges

    Tuesday, 22 March 2016 - 3:00 pm

    Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Meaningful digital initiatives need face time

    Wednesday, 10 February 2016 - 3:00 pm

    Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Authentic Engagement in Healthcare thumb Authentic Engagement in Healthcare

    Tuesday, 24 November 2015 - 2:00 pm

    What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Can medical technology afford market access?

    Wednesday, 18 November 2015 - 3:00 pm

    Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Drivers for change – payer value perceptions

    Tuesday, 22 September 2015 - 3:00 pm

    In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Sales reps in the digital age

    Thursday, 9 July 2015 - 1:00 pm

    As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Patient engagement: the future for outcomes research and clinical trials?

    Thursday, 25 June 2015 - 3:00 pm

    There is growing momentum and recognition among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research, including development and validation of Clinical Outcome Assessments, and participation of patients in clinical trials.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Next-generation KOL intelligence

    Wednesday, 13 May 2015 - 12:00 pm

    Advances in KOL intelligence are delivering richer insights into clinical landscapes than ever before, better enabling pharma to meet the challenges of an increasingly competitive and complex environment for KOL engagement.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Holistic market access Holistic market access and the importance of early engagement

    Wednesday, 10 December 2014 - 2:00 pm

    There are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a lot of talk about the former, but not so much about the latter.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

Previous 1 2 3 Next

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
arrow
The false economy of following the leader
How can companies in the sector shake things up?...

Infographics